Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun 20;211(3):304-11.
doi: 10.1016/j.toxlet.2012.04.008. Epub 2012 Apr 17.

Renal efflux transporter expression in pregnant mice with Type I diabetes

Affiliations

Renal efflux transporter expression in pregnant mice with Type I diabetes

Lindsay L Yacovino et al. Toxicol Lett. .

Abstract

Prior research suggests that sex hormones and metabolic changes, such as obesity and hyperglycemia, can alter renal transporter expression in rodents. The purpose of this study was to characterize the expression of kidney efflux transporters and regulatory transcription factors in response to Type I diabetes and pregnancy. Female C57BL/6 mice were treated with multiple low doses of streptozotocin (STZ) to induce hyperglycemia and then mated with normoglycemic male mice. Transporter mRNA and protein expression were quantified in kidneys from vehicle- and STZ-treated non-pregnant and pregnant mice on gestation day 14. Pregnancy decreased the expression of Mdr1b, Mrp4, and 5 proteins and increased the mRNA and protein expression of Mrp3 by 50-60%. STZ treatment elevated Mrp1, 2, 4, and 5 and reduced Mrp3, 6, and Mdr1b mRNA and/or protein in non-pregnant mice. Pregnancy had little effect on STZ-mediated changes in renal efflux transporter expression. Transcriptional profiles of Hnf1α, PXR, AhR, and Nrf2 were altered in patterns similar to some efflux transporters suggesting potential involvement in their regulation. Taken together, these results suggest that renal drug efflux transporters and regulatory signaling pathways are altered by endocrine and metabolic changes that occur during pregnancy and Type I diabetes.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Serum glucose levels in vehicle- and STZ-treated mice during pregnancy
Serum glucose levels of vehicle- and STZ-treated fed mice were quantified colorimetrically and presented as mean ± SE (n= 3-8 animals). Asterisks (*) represent a statistical difference compared to vehicle non-pregnant mice (p ≤ 0.05); Daggers () represent a statistical difference between vehicle and STZ-treated pregnant mice (p ≤ 0.05);
Figure 2
Figure 2. Renal mRNA expression of efflux transporters in vehicle- and STZ-treated mice during pregnancy
Total RNA was isolated from kidneys and mRNA levels were quantified using real-time quantitative PCR. The mRNA data for (A) apical transporters and (B) basolateral transporters are presented as means normalized to Rpl13a ± SE (n= 3-8 animals). Asterisks (*) represent a statistical difference compared to vehicle non-pregnant mice (p ≤ 0.05); Daggers () represent a statistical difference between vehicle and STZ-treated pregnant mice (p ≤ 0.05); Double daggers () represent a statistical difference between STZ-treated non-pregnant and pregnant mice (p ≤ 0.05).
Figure 3
Figure 3. Renal protein expression of efflux transporters in vehicle- and STZ-treated mice during pregnancy
Immunoblots are presented for (A) apical transporters and (B) basolateral transporters in the upper portion (protein loading amount 50 μg/lane). Protein band intensity was quantified by densitometry using an Alpha Innotech Fluorochem and presented as mean relative protein expression (normalized to the vehicle-treated non-pregnant experimental group) ± SE (n = 4 animals). β-actin was used as a loading control. Asterisks (*) represent a statistical difference compared to vehicle non-pregnant mice (p ≤ 0.05); Daggers () represent a statistical difference between vehicle and STZ-treated pregnant mice (p ≤ 0.05); Double daggers () represent a statistical difference between STZ-treated non-pregnant and pregnant mice (p ≤ 0.05).
Figure 4
Figure 4. Immunofluorescent detection of renal Mrp1, Mrp3, Mrp4, and Mrp6 efflux transporters in vehicle- and STZ-treated mice during pregnancy
Indirect immunofluorescence staining using MRPr1, M3II-2, M4I-10, and M6II-68 antibodies was conducted on kidney cryosections (6 μm) obtained from gestation day 14 vehicle- and STZ-treated mice during pregnancy. Images are shown at 10X magnification. Images were cropped, enlarged, and provided as insets.
Figure 5
Figure 5. Renal mRNA expression of transcription factors in vehicle- and STZ-treated mice during pregnancy
Total RNA was isolated from kidneys and mRNA levels were quantified using real-time quantitative PCR. The data are presented as means normalized to Rpl13a ± SE (n= 3-8 animals). Asterisks (*) represent a statistical difference compared to vehicle non-pregnant mice (p ≤ 0.05); Daggers () represent a statistical difference between vehicle and STZ-treated pregnant mice (p ≤ 0.05); Double daggers () represent a statistical difference between STZ-treated non-pregnant and pregnant mice (p ≤ 0.05).
Figure 6
Figure 6. Renal mRNA expression of antioxidant enzymes Nqo1 and Ho-1 and the Nrf2 transcription factor in vehicle- and STZ-treated mice during pregnancy
Total RNA was isolated from kidneys and mRNA levels were quantified using real-time quantitative PCR. The data are presented as means normalized to Rpl13a ± SE (n= 3-8 animals). Asterisks (*) represent a statistical difference compared to vehicle non-pregnant mice (p ≤ 0.05); Daggers () represent a statistical difference between vehicle and STZ-treated pregnant mice (p ≤ 0.05); Double daggers () represent a statistical difference between STZ-treated non-pregnant and pregnant mice (p ≤ 0.05).
Figure 7
Figure 7. Differential expression of renal efflux transporters during diabetes and pregnancy
Relative changes in mRNA and/or protein expression of efflux transporters in STZ-treated diabetic or pregnant mice are summarized.

Similar articles

Cited by

References

    1. Aleksunes LM, Augustine LM, Scheffer GL, Cherrington NJ, Manautou JE. Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment. Toxicology. 2008a;250:82–88. - PMC - PubMed
    1. Aleksunes LM, Cui Y, Klaassen CD. Prominent expression of xenobiotic efflux transporters in mouse extraembryonic fetal membranes compared with placenta. Drug Metab Dispos. 2008b;36:1960–1970. - PMC - PubMed
    1. Aleksunes LM, Goedken MJ, Rockwell CE, Thomale J, Manautou JE, Klaassen CD. Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity. J Pharmacol Exp Ther. 2010;335:2–12. - PMC - PubMed
    1. Aleksunes LM, Scheffer GL, Jakowski AB, Pruimboom-Brees IM, Manautou JE. Coordinated expression of multidrug resistance-associated proteins (Mrps) in mouse liver during toxicant-induced injury. Toxicol Sci. 2006;89:370–379. - PubMed
    1. Aleksunes LM, Slitt AL, Maher JM, Augustine LM, Goedken MJ, Chan JY, Cherrington NJ, Klaassen CD, Manautou JE. Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2. Toxicol Appl Pharmacol. 2008c;226:74–83. - PMC - PubMed

Publication types

MeSH terms